NEW YORK, Nov. 20 (GenomeWeb News) - Sionex, which is commercializing chemical sensor chips for biopharmaceutical and other applications, raised $12.8 million in a Series B round of funding, the company said today.
The funding was led by Morgenthaler Ventures, with additional funds from Rho Ventures and Navigator Technology Ventures, which are existing investors in the Waltham, Mass., company.
The company plans to use the capital to further develop and manufacture its products, and to expand partnerships. In October, Sionex signed a deal with Varian to incorporate its microDMx technology into Varian's gas chromatography products. The company is also positioning its sensor technology as applicable to detection of chemical and biological agents for defense and homeland security applications, and to the biopharmaceutical, environmental, commercial, and diagnostic applications.
Sionex's microDMx technology is based on the technique of Field Asymetric Ion Mobility Spectrometry, or FAIMS, and its microfabrication in a MEMS format.